GLYTHERA

Welcome to the Brand page for “GLYTHERA”, which is offered here for Paper; cardboard; printed matter, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, data packages, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; printed instructional, educational, and teaching materials in the field of medicine; publications, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, magazines, newsletters, research articles in the field of medicine;chemicals used in industry and science; chemical products for use in industry and science, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; in-vivo diagnostic reagents; chemical preparations for scientific and industrial processes, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for scientific and industrial purposes; biological cell cultures for use in scientific research; all the aforementioned goods excluding goods in the field of gene therapy;scientific and technological services, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; industrial analysis and research services, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; biological research; biotechnology testing services, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines, biotherapeutics and antibody-drug conjugates; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; information, advisory and consultancy services relating to the aforesaid; all the aforementioned services excluding services in the field of gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “GLYTHERA” is believed to be currently owned by “IKSUDA THERAPEUTICS LIMITED”.